Elanco Animal Health Incorporated Common Stock vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $61.09 (market cap $44.49B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 4× Elanco Animal Health Incorporated Common Stock's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and JPMorgan Nasdaq Equity Premium Income ETF for 66 Days on average.
| ELAN | JEPQ | |
|---|---|---|
Market Cap | $11.26B | $44.49B |
Volume | 4,570,386 | 5,681,789 |
Sector | Health | Income / Options Overlay |
52-Week High | $26.84 | $61.46 |
52-Week Low | $19.76 | $53.77 |
Typical Hold Time | 1 Days | 66 Days |
Enterprise Value | $14.65B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JEPQ trades at $61.09, down 0.29% on the day, with a bullish technical signal driven by moving averages. The ETF maintains strong income generation through its covered-call strategy, with recent monthly dividends ranging from $0.57 to $0.70. Technical analysis shows support at $60-61 and resistance at $61-62, while oscillators remain neutral with RSI at 47.13.
JEPQ offers high monthly income potential with an estimated 11% yield, though its covered-call strategy limits upside appreciation. The ETF provides exposure to Nasdaq technology stocks with downside protection during volatility. Key risks include market correlation, income variability, and competition from other income ETFs. Institutional interest remains strong, with Envestnet recently increasing its position.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →